phase readout
saveNCT04748419: Safety & Efficacy of Consolidative Hypofractionated Radiation Therapy for Boosting Residual Lung Cancer With Durvalumab
TERMINATEDupdated 8h ago
community read0 votes
Sponsor: University of Nebraska. Phase: PHASE1. Conditions: Lung Cancer, Carcinoma, Non-Small Cell Lung
view source ↗
comments(0)
5-min edit window · permanent after that